Ophtalmopharma

Switzerland
Obwalden, Sarnen, Switzerland
+41 61 931 46 40 ★

Company profile

Ophtalmopharma company profile

OphthalmoPharma (OPPH) is a pharmaceutical company specializing in the development of ophthalmology treatments. Their product pipeline addresses major unmet medical needs including dry eye syndrome, glaucoma, and age-related macular degeneration (AMD). Ophthalmopharma has granted Altacor exclusive rights for its two proprietary therapeutic products for the treatment of glaucoma and dry eye as well as exclusive rights for its EyeBar, a nutraceutical for the prevention of dry AMD and the preloaded injector for delivery of intraocular lens in cataract and corrective lens replacement surgery (currently known as SOLO).

Business identity

Phone number
+41 61 931 46 40
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Founded
2003-01-01

Headquarters

Headquarters
Obwalden, Sarnen, Switzerland
Postal code
CH 6060
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Last funding
Series A / 2007-01-01
Last equity funding
Series A
Investors
1

Categories and groups

Founders and investors

Investors

Armilar Venture Partners

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.